Psoriatic Arthritis and Osteoporosis

Angie Szumlinski News

A recent study published in Arthritis Care and Research, investigators found a similar prevalence of osteoporosis and osteopenia in patients with psoriatic arthritis compared to the general population. Patients with psoriatic arthritis who are more likely to undergo osteoporosis screening are those with traditional risk factors including age and menopause, as well as those with features suggestive of higher disease …

Osteoporosis Treatment Beyond 5 Years

Angie Szumlinski Health, Studies

For more than 2 decades, bisphosphonate drugs have been a first-line therapy for preventing osteoporotic fractures, based on strong clinical evidence showing significant fracture risk reduction within the first 3 to 5 years of treatment. However, data regarding the optimal duration of bisphosphonate treatment to minimize fracture risk beyond this initial period of time are limited. In September 2015, a …

Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention

Angie Szumlinski Health, News

A recent study to summarize the effects of long-term osteoporosis drug treatment and of osteoporosis drug treatment discontinuation and holidays found that long-term alendronate, zoledronate, and oral hormone therapy reduced nonvertebral fractures in older women, with oral hormone therapy also reducing hip fractures. While absolute reductions in typical fractures with long-term bisphosphonates are large relative to increases in AFF, reduced …